scispace - formally typeset
Open AccessJournal ArticleDOI

Applications of single-cell sequencing in cancer research: progress and perspectives

TLDR
The use of single-cell sequencing in cancer research has revolutionized our understanding of the biological characteristics and dynamics within cancer lesions, including information related to the landscapes of malignant cells and immune cells, tumor heterogeneity, circulating tumor cells and underlying mechanisms of tumor biological behaviors as mentioned in this paper.
Abstract
Single-cell sequencing, including genomics, transcriptomics, epigenomics, proteomics and metabolomics sequencing, is a powerful tool to decipher the cellular and molecular landscape at a single-cell resolution, unlike bulk sequencing, which provides averaged data. The use of single-cell sequencing in cancer research has revolutionized our understanding of the biological characteristics and dynamics within cancer lesions. In this review, we summarize emerging single-cell sequencing technologies and recent cancer research progress obtained by single-cell sequencing, including information related to the landscapes of malignant cells and immune cells, tumor heterogeneity, circulating tumor cells and the underlying mechanisms of tumor biological behaviors. Overall, the prospects of single-cell sequencing in facilitating diagnosis, targeted therapy and prognostic prediction among a spectrum of tumors are bright. In the near future, advances in single-cell sequencing will undoubtedly improve our understanding of the biological characteristics of tumors and highlight potential precise therapeutic targets for patients.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

TL;DR: In this paper , the classification and inhibitory function of myeloid-derived suppressor cells (MDSCs) and the crosstalk between MDSCs and other myeloids are discussed.
Journal ArticleDOI

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors

TL;DR: In this paper , a review of single-cell transcriptomics and spatial transcriptomics for the studies of the systemic tumor immune microenvironment (STIE) and their interactions is presented, which may reveal heterogeneity in immunotherapy responses as well as the dynamic changes essential for the treatment effect.
Journal ArticleDOI

Single cell cancer epigenetics.

TL;DR: In this paper , a review of single cell-sequencing methodologies for cancer is presented, focusing on different aspects of epigenetics (DNA methylation, chromatin accessibility, histone modifications, DNA-protein interactions, and chromatin 3D architecture) at the single cell level.
Journal ArticleDOI

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing

TL;DR: In this article , the authors performed scRNA-seq on 72,475 immune cells from 40 samples of tumor and matched adjacent normal tissues spanning 19 NSCLC patients, and drew a systematic immune cell transcriptome atlas.
Journal ArticleDOI

Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer

TL;DR: In this paper , the authors combine single-nucleus RNA sequencing (snRNA-seq) with a microarray-based spatial transcriptomics (ST) to identify cell populations and their spatial distribution in breast cancer tissues, and find that these subclusters are mapped in distinct tissue regions, where discrepant enrichment of stromal cell types are observed.
References
More filters
Journal ArticleDOI

Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma

TL;DR: An in vitro cell culture model for ESCC radioresistance that mimics the common radiotherapy process in patients with ESCC identified a number of signaling molecules associated with radiores resistance, as well as opportunities for the development of novel therapeutic options for the treatment of ESCC.
Journal ArticleDOI

Effect of lncRNA‑BC200 on proliferation and migration of liver cancer cells in vitro and in vivo.

TL;DR: It was found that BC200 expression level was higher in hepatocellular carcinoma (HCC) tissues than that in adjacent tissues and it was suggested that lncRNA BC200 may play an important role in liver cancer.
Journal ArticleDOI

Single‑cell intratumoral stemness analysis reveals the involvement of cell cycle and DNA damage repair in two different types of esophageal cancer

TL;DR: By comparing the transcriptomic profiles of single cancer cells with high and low stemness in individual patients, it was revealed that the overexpression of cell cycle-associated genes in EAC cells was highly correlated with stemness, whereas overeexpression of genes involved in the signaling pathways of DNA replication and DNA damage repair was significantly correlated withstemness in ESCC.
Journal ArticleDOI

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.

TL;DR: GLRX-targeted cell redox regulatory therapy may enhance the efficacy of glioma immunotherapy and be a potential marker for the mesenchymal molecular subtype ofgliomas.
Journal ArticleDOI

Research Techniques Made Simple: Use of Imaging Mass Cytometry for Dermatological Research and Clinical Applications.

TL;DR: For example, Imaging mass cytometry (IMC) as discussed by the authors combines IHC using metal-labeled antibodies with laser ablation and detection using mass cytology by time-of-flight to generate high-dimensional images from a single tissue section.
Related Papers (5)